Login / Signup

The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent.

Michael HaudeStephen W L LeeStephen G WorthleySigmund SilberStefan VerheyeMohd A RosliRoberto BotelhoKui H SimAlexandre AbizaidRoxana Mehrannull null
Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
At 5-year follow-up, the Combo stent remained clinically safe and effective with an overall low rate of MACE comparable to Taxus.
Keyphrases
  • study protocol
  • clinical trial
  • endothelial cells
  • phase iii
  • phase ii
  • randomized controlled trial